Chihuei Wang

发表

Multimodality treatment and long-term follow-up of the primary pulmonary lymphoepithelioma-like carcinoma.

Yueh-Fu Fang, Chih-Teng Yu, Chia-Chuan Liu, 2012, Clinical lung cancer.

Quantitative Proteomics Reveals Regulation of Karyopherin Subunit Alpha-2 (KPNA2) and Its Potential Novel Cargo Proteins in Nonsmall Cell Lung Cancer *□S

Yu-Sun Chang, Jau-Song Yu, K. Chien, 2012 .

Association of smoking status with non-small cell lung cancer patients harboring uncommon epidermal growth factor receptor mutation

Tsung-Ying Yang, Chien-Ying Liu, Cheng-Ta Yang, 2022, Frontiers in Immunology.

Methods for Collection of Extracellular Vesicles and Their Content RNA as Liquid Biopsy for Lung Cancer Detection: Application of Differential Centrifugation and Annexin A5 Coated Beads

How-Wen Ko, P. Chang, C. Chiou, 2022, Current issues in molecular biology.

Overall Survival Improvement in Patients with Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer and Bone Metastasis Treated with Denosumab

Chih-Teng Yu, Tsung-Ying Yang, Chien-Ying Liu, 2022, Cancers.

Quantitative Proteomics Reveals Regulation of Karyopherin Subunit Alpha-2 (KPNA2) and Its Potential Novel Cargo Proteins in Nonsmall Cell Lung Cancer *

Yu-Sun Chang, Jau-Song Yu, K. Chien, 2012, Molecular & Cellular Proteomics.

HOXB13 homeodomain protein suppresses the growth of prostate cancer cells by the negative regulation of T-cell factor 4.

C. Jung, Sang-Jin Lee, M. Jeng, 2004, Cancer research.

Factor 4 Prostate Cancer Cells by the Negative Regulation of T-Cell HOXB 13 Homeodomain Protein Suppresses the Growth of Updated

C. Jung, Sang-Jin Lee, M. Jeng, 2004 .

Importin subunit alpha‐2 is identified as a potential biomarker for non‐small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome

Yu-Sun Chang, Jau-Song Yu, Chih-Ching Wu, 2011, International journal of cancer.

Transcriptomic Analysis in Liquid Biopsy Identifies Circulating PCTAIRE-1 mRNA as a Biomarker in NSCLC

Chia-Jung Yu, Ji-Dung Luo, C. Chiou, 2019, Cancer Genomics & Proteomics.

Population alterations of l-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14−/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer

Fu-Tsai Chung, Shu-Min Lin, Horng-Chyuan Lin, 2009, Journal of Cancer Research and Clinical Oncology.

Nuclear accumulation of KPNA2 impacts radioresistance through positive regulation of the PLSCR1‐STAT1 loop in lung adenocarcinoma

Kwang-Huei Lin, Wei-Chao Liao, Chia-Jung Yu, 2021, Cancer science.

Continuous epidermal growth factor receptor-tyrosine kinase inhibitor administration in primary lung adenocarcinoma patients harboring favorable mutations with controlled target lung tumors dose not hinder survival benefit despite small new lesions

Chih-Teng Yu, Cheng-Ta Yang, K. Kao, 2016, Biomedical journal.

Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non‐small cell lung cancer

Fu-Tsai Chung, Chien-Ying Liu, How-Wen Ko, 2019, Thoracic cancer.

Radiotherapy enhances CXCR3highCD8+ T cell activation through inducing IFNγ-mediated CXCL10 and ICAM-1 expression in lung cancer cells

C. Peng, Jungshan Chang, A. Ho, 2023, Cancer Immunology, Immunotherapy.

Quantitative proteomics reveals a novel role of karyopherin alpha 2 in cell migration through the regulation of vimentin-pErk protein complex levels in lung cancer.

Yu-Sun Chang, Jau-Song Yu, Chia-Jung Yu, 2015, Journal of proteome research.

mTOR regulates proteasomal degradation and Dp1/E2F1- mediated transcription of KPNA2 in lung cancer cells

Yu-Sun Chang, Jau-Song Yu, Chia-Jung Yu, 2016, Oncotarget.

OTT_A_221832 11475..11486

Chia-Jung Yu, Jie-Xin Huang, Yi-Cheng Wu, 2019 .

IRF1 Negatively Regulates Oncogenic KPNA2 Expression Under Growth Stimulation and Hypoxia in Lung Cancer Cells

Chia-Jung Yu, Chihuei Wang, Yanmin Cheng, 2019 .